Thermo Fisher Scientific Inc
Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportJul 31 →InsidersNo open-market buys. 6 insiders sold $96.6M, 59 of 67 sales on a 10b5-1 plan.→HoldersBlackRock 6.9%Vanguard 5.4%State Street 3.8%→Financing →PeersClosest companies: WAT, DCI, HBIO→
From the filings
Figures
- Revenue
- $46.34Blast 12 months
- Net income
- $6.98Blast 12 months
- Operating cash flow
- $8.29Blast 12 months
- Cash and equivalents
- $4.06Bat the last balance sheet
- Total debt
- $45.65Bat the last balance sheet
- Shares outstanding
- 445.7M shareson issue